FrancophonIA/ELRC3.0 huggingface dataset:
English: The following changes, observed in rats and macaques receiving the irbesartan/hydrochlorothiazide combination at 10/10 and 90/90 mg/kg/day, were also seen with one of the two medicinal products alone and/or were secondary to decreases in blood pressure (no significant toxicologic interactions were observed): kidney changes, characterized by slight increases in serum urea and creatinine, and hyperplasia/hypertrophy of the juxtaglomerular apparatus, which are a direct consequence of the interaction of irbesartan with the renin-angiotensin system; slight decreases in erythrocyte parameters (erythrocytes, haemoglobin, haematocrit); stomach discoloration, ulcers and focal necrosis of gastric mucosa were observed in few rats in a 6 months toxicity study at irbesartan 90 mg/kg/day, hydrochlorothiazide 90 mg/kg/day, and irbesartan/hydrochlorothiazide 10/10 mg/kg/day.
Danish: Følgende ændringer, observeret hos rotter og makakaber, der fik en kombination af irbesartan/hydrochlorthiazid på 10/10 og 90/90 mg/kg/dag, blev også set ved anvendelse af de individuelle stoffer og/eller var sekundære til blodtryksnedsættelse (der blev ikke observeret signifikante toksikologiske interaktioner): nyreforandringer karakteriseret ved let øgning af serum-urea og kreatinin samt hyperplasi/hypertrofi af det juxtaglomerulære apparat, hvilket er en direkte konsekvens af interaktion mellem irbesartan og renin-angiotensin-systemet; let fald i erytrocytparametre (erytrocytter, hæmoglobin, hæmatokrit); i et 6 måneders toksicitetsstudie med irbesartan 90 mg/kg/dag, hydrochlorthiazid 90 mg/kg/dag, og irbesartan/hydrochlorthiazid 10/10 mg/kg/dag blev der observeret misfarvning, sår og fokal nekrose af ventrikelslimhinden hos rotter.
English: Such conditions should be corrected before initiating therapy with Irbesartan Hydrochlorothiazide BMS.
Danish: Sådanne tilstande skal korrigeres inden initiering af behandling med Irbesartan Hydrochlorothiazide BMS.
English: Antigout medicinal products: dosage adjustments of antigout medicinal products may be necessary as hydrochlorothiazide may raise the level of serum uric acid.
Danish: Lægemidlerr mod urinsyregigt: Det kan være nødvendigt at justere dosis af lægemidler mod urinsyregigt, da hydrochlorthiazid kan øge niveauet af urinsyre i serum.
English: Always take Irbesartan Hydrochlorothiazide BMS exactly as your doctor has told you.
Danish: Tag altid Irbesartan Hydrochlorothiazide BMS nøjagtigt efter lægens anvisning.
English: Titanium dioxide Macrogol 3000
Danish: Lactosemonohydrat Hypromellose Titandioxid Macrogol 3000
English: Increases in cholesterol and triglyceride levels have been associated with thiazide diuretic therapy; however at the 12.5 mg dose contained in Irbesartan Hydrochlorothiazide BMS, minimal or no effects were reported.
Danish: Thiazidbehandling er associeret med forhøjede kolesterol- og triglycerid-niveauer, Der er dog rapporteret minimal eller ingen effekt ved en dosis på 12,5 mg som findes i Irbesartan Hydrochlorothiazide BMS.
English: There is no difference in response to Irbesartan Hydrochlorothiazide BMS, regardless of age or gender.
Danish: Virkningen af Irbesartan Hydrochlorothiazide BMS afhænger ikke af alder eller køn.
English: Because no information is available regarding the use of Irbesartan Hydrochlorothiazide BMS during breast-feeding, Irbesartan Hydrochlorothiazide BMS is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Danish: Da der ikke foreligger oplysninger om anvendelse af Irbesartan Hydrochlorothiazide BMS under amning, frarådes brugen af Irbesartan Hydrochlorothiazide BMS, og andre behandlinger med en mere veletableret sikkerhedsprofil for anvendelse under amning foretrækkes.
English: Irbesartan Hydrochlorothiazide BMS should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/min) (see section 4.3).
Danish: Irbesartan Hydrochlorothiazide BMS må ikke anvendes til patienter med alvorlig nyrefunktionsnedsættelse (kreatininclearance < 30 ml/min) (se pkt.
English: Irbesartan Hydrochlorothiazide BMS can be taken once daily, with or without food.
Danish: Irbesartan Hydrochlorothiazide BMS kan administreres 1 gang dagligt med eller uden samtidig fødeindtagelse.
English: Side effects reported in clinical studies for patients treated with Irbesartan Hydrochlorothiazide BMS were:
Danish: Følgende bivirkninger er indberettet i medicinske forsøg med patienter, som fik Irbesartan Hydrochlorothiazide BMS:
English: Medicinal products affected by serum potassium disturbances: periodic monitoring of serum potassium is recommended when Irbesartan Hydrochlorothiazide BMS is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics).
Danish: Lægemidler, der påvirkes af serum-kaliumforstyrrelser: Det anbefales at måle serum-kalium periodisk, når Irbesartan Hydrochlorothiazide BMS administreres sammen med lægemidler, der påvirkes af serum-kaliumforstyrrelser (fx digitalis glykosider, antiarytmika).
English: These undesirable effects are: headache, ringing in the ears, cough, taste disturbance, indigestion, pain in joints and muscles, liver function abnormal and impaired kidney function, increased level of potassium in your blood and allergic reactions such as rash, hives, swelling of the face, lips, mouth, tongue or throat.
Danish: Disse bivirkninger er: hovedpine, ringen for ørerne, hoste, smagsforstyrrelser, forstoppelse, led- og muskelsmerter, leversygdom og nedsat nyrefunktion, øget mængde af kalium i blodet og allergiske reaktioner såsom udslæt, nældefeber,opsvulmet ansigt, læber, mund, tunge og hals.
English: When necessary, Irbesartan Hydrochlorothiazide BMS may be administered with another antihypertensive medicinal product (see section 4.5).
Danish: Om nødvendigt kan Irbesartan Hydrochlorothiazide BMS kombineres med andre antihypertensiva (se pkt.
English: Irbesartan Hydrochlorothiazide BMS is a combination of two active substances, irbesartan and hydrochlorothiazide.
Danish: Irbesartan Hydrochlorothiazide BMS indeholder en kombination af to aktive lægemidler, irbesartan og hydrochlorthiazid.
English: There is no experience regarding the administration of Irbesartan Hydrochlorothiazide BMS in patients with a recent kidney transplantation.
Danish: Der er ingen erfaring med administration af Irbesartan Hydrochlorothiazide BMS til nyligt nyretransplanterede patienter.
English: There is no clinical experience with Irbesartan Hydrochlorothiazide BMS in patients with hepatic impairment.
Danish: Der er ingen klinisk erfaring med Irbesartan Hydrochlorothiazide BMS hos patienter med nedsat leverfunktion.
English: Marketing Authorisation Holder BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road
Danish: Indehaver af markedsføringstilladelsen BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road
English: if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant if you suffer from heart problems if you suffer from liver problems if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
Danish: Vær ekstra forsigtig med at bruge Irbesartan Hydrochlorothiazide BMS: Kontakt lægen hvis du oplever følgende: hvis du får hyppig opkastning eller diarré hvis du lider af nyreproblemer eller er nyretransplanteret hvis du lider af hjerteproblemer hvis du lider af leverproblemer hvis du lider af sukkersyge hvis du lider af erytematøs lupus (også kaldet lupus eller systemisk lupus erythematosus) hvis du lider af primær aldosteronisme (tilstand med høj produktion af hormonet aldosteron, som gør, at der ophobes natriumsalt i kroppen, og blodtrykket derfor stiger).
English: Preparations containing lithium should not be taken with Irbesartan Hydrochlorothiazide BMS without close supervision by your doctor.
Danish: Tag ikke medicin, der indeholder lithium, samtidig med at du tager Irbesartan Hydrochlorothiazide BMS uden grundig vejledning fra lægen.
English: Irbesartan Hydrochlorothiazide BMS will usually be prescribed by your doctor when your previous treatment did not reduce your blood pressure enough.
Danish: Lægen vil sandsynligvis starte behandling med Irbesartan Hydrochlorothiazide BMS, hvis den tidligere behandling ikke sænkede dit blodtryk tilstrækkeligt.
English: Tables 2 and 3 below detail the adverse reactions reported with the individual components of Irbesartan Hydrochlorothiazide BMS.
Danish: Tabel 2 og 3 viser bivirkningerne af de individuelle stoffer i Irbesartan Hydrochlorothiazide BMS.
English: Therefore, the use of Irbesartan Hydrochlorothiazide BMS is not recommended.
Danish: Derfor frarådes brug af Irbesartan Hydrochlorothiazide BMS.
English: Lithium: the combination of lithium and Irbesartan Hydrochlorothiazide BMS is not recommended (see section 4.5).
Danish: Lithium: Kombination af lithium og Irbesartan Hydrochlorothiazide BMS frarådes (se pkt.
English: Hepatic impairment: Irbesartan Hydrochlorothiazide BMS is not indicated in patients with severe hepatic impairment.
Danish: Leverfunktionsnedsættelse: Irbesartan Hydrochlorothiazide BMS er ikke indiceret til patienter med svært nedsat leverfunktion.
English: Due to the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide BMS, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up, specially when getting up from a sitting position.
Danish: Hvis du drikker alkohol, mens du er i behandling med dette produkt, kan du opleve, at du bliver mere svimmel, især når du rejser dig op fra siddende stilling.
English: Cartons of 56 x 1 tablets; 7 blister cards of 8 x 1 tablets each in PVC/PVDC/Aluminium perforated unit dose blisters.
Danish: Kartoner med 56 x 1 tablet; 7 blisterkort med 8 x 1 tablet i PVC/PVDC/perforerede aluminiumblistere med enkeltdosis.
English: No dosage adjustment of Irbesartan Hydrochlorothiazide BMS is necessary in patients with mild to moderate hepatic impairment (see section 4.3).
Danish: Dosisjustering af Irbesartan Hydrochlorothiazide BMS til patienter med mild eller moderat leverfunktionsnedsættelse er ikke nødvendig (se pkt.
English: Hypersensitivity to the active substances, to any of the excipients (see section 6.1), or to other sulfonamide-derived substances (hydrochlorothiazide is a sulfonamide-derived substance) Second and third trimesters of pregnancy (see sections 4.4 and 4.6) Severe renal impairment (creatinine clearance < 30 ml/min) Refractory hypokalaemia, hypercalcaemia
Danish: 6.1) eller over for andre sulfonamidderivater (hydrochlorthiazid er et sulfonamidderivat) Graviditet i 2. eller 3. trimester (se pkt.
English: The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3350, red, yellow and black ferric oxides, pregelatinized starch, carnauba wax.
Danish: Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, hypromellose, silicondioxid, magnesiumstearat, titandioxid, macrogol 3350, rød, gul og sort jernoxid, prægelatiniseret majsstivelse, carnaubavoks.
English: You should check with your doctor or pharmacist if you are not sure.
Danish: Spørg lægen eller på apoteket hvis der er noget, du er i tvivl om eller føler dig usikker på.
English: The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, red and yellow ferric oxides, carnauba wax.
Danish: Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, hypromellose, silicondioxid, magnesiumstearat, titandioxid, macrogol 3000, rød og gul jernoxid, carnaubavoks.
English: HOW TO TAKE IRBESARTAN HYDROCHLOROTHIAZIDE BMS
Danish: SÅDAN SKAL DU BRUGE IRBESARTAN HYDROCHLOROTHIAZIDE BMS
English: Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate
Danish: Mikrokrystallinsk cellulose Croscarmellosenatrium Lactosemonohydrat Magnesiumstearat Kolloid silica
English: Irbesartan Hydrochlorothiazide BMS is for oral use.
Danish: Irbesartan Hydrochlorothiazide BMS skal tages gennem munden.
English: The trough to peak effects measured by cuff during office visits were 68% and 76% for Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg and Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg, respectively.
Danish: Forholdet mellem den laveste og den maksimale effekt var henholdsvis 68% og 76% for Irbesartan Hydrochlorothiazide BMS 150 mg /12,5 mg og Irbesartan Hydrochlorothiazide BMS 300 mg /12,5 mg, når effekten blev målt med blodtryksmanchet ved kontrolbesøg.
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg
English: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg may be administered in patients insufficiently controlled by Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg.
Danish: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg kan gives til patienter, der er utilstrækkeligt regulerede med Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg.
English: Therefore, the combination of lithium and Irbesartan Hydrochlorothiazide BMS is not recommended (see section 4.4).
Danish: Derfor frarådes kombination af lithium og Irbesartan Hydrochlorothiazide BMS (se pkt.
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/017-022
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/06/369/017-022
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/001-005
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/06/369/001-005
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/006-010
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/06/369/006-010
English: Efficacy and safety of Irbesartan Hydrochlorothiazide BMS as initial therapy for severe hypertension (defined as SeDBP ≥ 110 mmHg) was evaluated in a multicenter, randomized, double-blind, active controlled, 8-week, parallel-arm study.
Danish: Et randomiseret, dobbeltblindt, aktivt kontrolleret, parallelt multicenterforsøg af 8 ugers varighed har evalueret effekten og sikkerheden af Irbesartan Hydrochlorothiazide BMS som inital behandling ved svær hypertension (defineret som SeDBT ≥ 110 mmHg).
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/023-028
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/06/369/023-028
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/011-016
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/06/369/011-016
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 150 mg and hydrochlorothiazide 12.5 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 150 mg og hydrochlorthiazid 12,5 mg
English: What Irbesartan Hydrochlorothiazide BMS is and what it is used for Before you take Irbesartan Hydrochlorothiazide BMS How to take Irbesartan Hydrochlorothiazide BMS Possible side effects
Danish: Det skal du vide, før du begynder at bruge Irbesartan Hydrochlorothiazide BMS Sådan skal du bruge Irbesartan Hydrochlorothiazide BMS Bivirkninger
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 25 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 300 mg og hydrochlorthiazid 25 mg
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg
English: After either oral or intravenous administration of 14C irbesartan, about 20% of the radioactivity is recovered in the urine, and the remainder in the faeces.
Danish: genfindes ca. 20% radioaktivitet i urinen og resten i afføringen.
English: Each film-coated tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Danish: Hver tablet af Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg tabletter indeholder 300 mg irbesartan og 25 mg hydrochlorthiazid.
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 12.5 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 300 mg og hydrochlorthiazid 12,5 mg
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg
English: Although not specifically studied with the Irbesartan Hydrochlorothiazide BMS, rebound hypertension has not been seen with either irbesartan or hydrochlorothiazide.
Danish: Der er hverken observeret rebound-hypertension for irbesartan eller hydrochlorthiazid.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg filmovertrukne tabletter.
English: Cartons of 56 tablets; 4 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Kartoner med 56 tabletter; 4 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere
English: Each tablet of Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Danish: Hver tablet af Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg tabletter indeholder 150 mg irbesartan og 12,5 mg hydrochlorthiazid.
English: Cartons of 14 tablets; 1 blister card of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Kartoner med 14 tabletter; 1 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere
English: Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Danish: Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter.
English: hyperkalaemia
Danish: Hyperkalæmi
English: BEFORE YOU TAKE IRBESARTAN HYDROCHLOROTHIAZIDE BMS
Danish: DET SKAL DU VIDE, FØR DU BEGYNDER AT BRUGE IRBESARTAN HYDROCHLOROTHIAZIDE BMS
English: Cartons of 98 tablets; 7 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Kartoner med 98 tabletter; 7 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere
English: Cartons of 28 tablets; 2 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Kartoner med 28 tabletter; 2 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere
English: Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Danish: Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter.
English: dizziness
Danish: Svimmelhed
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg filmovertrukne tabletter.
English: What Irbesartan Hydrochlorothiazide BMS contains The active substances are irbesartan and hydrochlorothiazide.
Danish: De aktive stoffer er irbesartan og hydrochlorthiazid.
English: Each tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Danish: Hver tablet af Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg tabletter indeholder 300 mg irbesartan og 12,5 mg hydrochlorthiazid.
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets are pink, biconvex, ovalshaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Danish: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg filmovertrukne tabletter er lyserød, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2788 på den anden side.
English: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Danish: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.
English: EU/1/06/369/017 - 14 tablets EU/1/06/369/018 - 28 tablets EU/1/06/369/019 - 56 tablets EU/1/06/369/020 - 56 x 1 tablets EU/1/06/369/021 - 84 tablets EU/1/06/369/022 - 98 tablets
Danish: EU/1/06/369/017 - 14 tabletter EU/1/06/369/018 - 28 tabletter EU/1/06/369/019 - 56 tabletter EU/1/06/369/020 - 56 x 1 tabletter EU/1/06/369/021 - 84 tabletter EU/1/06/369/022 - 98 tabletter
English: Excipient:
Danish: Amning:
English: EU/1/06/369/011 - 14 tablets EU/1/06/369/012 - 28 tablets EU/1/06/369/013 - 56 tablets EU/1/06/369/014 - 56 x 1 tablets EU/1/06/369/015 - 84 tablets EU/1/06/369/016 - 98 tablets
Danish: EU/1/06/369/011 - 14 tabletter EU/1/06/369/012 - 28 tabletter EU/1/06/369/013 - 56 tabletter EU/1/06/369/014 - 56 x 1 tabletter EU/1/06/369/015 - 84 tabletter EU/1/06/369/016 - 98 tabletter
English: EU/1/06/369/023 - 14 tablets EU/1/06/369/024 - 28 tablets EU/1/06/369/025 - 56 tablets EU/1/06/369/026 - 56 x 1 tablets EU/1/06/369/027 - 84 tablets EU/1/06/369/028 - 98 tablets
Danish: EU/1/06/369/023 - 14 tabletter EU/1/06/369/024 - 28 tabletter EU/1/06/369/025 - 56 tabletter EU/1/06/369/026 - 56 x 1 tabletter EU/1/06/369/027 - 84 tabletter EU/1/06/369/028 - 98 tabletter
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg filmovertrukne tabletter.
English: Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Danish: Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.
English: Take special care with Irbesartan Hydrochlorothiazide BMS Tell your doctor if any of the following apply to you:
Danish: Hvis du vil have yderligere oplysninger om Irbesartan Hydrochlorothiazide BMS, skal du henvende dig til den lokale repræsentant:
English: Lactation:
Danish: Dosis:
English: EU/1/06/369/001 - 14 tablets EU/1/06/369/002 - 28 tablets EU/1/06/369/003 - 56 tablets EU/1/06/369/004 - 56 x 1 tablets EU/1/06/369/005 - 98 tablets
Danish: EU/1/06/369/001 - 14 tabletter EU/1/06/369/002 - 28 tabletter EU/1/06/369/003 - 56 tabletter EU/1/06/369/004 - 56 x 1 tabletter EU/1/06/369/005 - 98 tabletter
English: EU/1/06/369/006 - 14 tablets EU/1/06/369/007 - 28 tablets EU/1/06/369/008 - 56 tablets EU/1/06/369/009 - 56 x 1 tablets EU/1/06/369/010 - 98 tablets
Danish: EU/1/06/369/006 - 14 tabletter EU/1/06/369/007 - 28 tabletter EU/1/06/369/008 - 56 tabletter EU/1/06/369/009 - 56 x 1 tabletter EU/1/06/369/010 - 98 tabletter
English: Cartons of 84 film-coated tablets; 6 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Kartoner med 84 tabletter; 6 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg filmovertrukne tabletter irbesartan/hydrochlorthiazid
English: Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Danish: Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.